One thing that I think we are not short of on the Australian share market is small cap shares with bucket loads of growth potential.
Three up and coming shares that I think investors should be keeping a close eye on are listed below. Here's why I think they are worthy of a place on your watchlist:
Bubs Australia Ltd (ASX: BUB)
I'm sure all our readers will be very familiar with the infant formula boom that companies such as A2 Milk Company Ltd (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL) are experiencing in China. Bubs is aiming to follow in their footsteps with its goats milk offering. Management has been extremely busy signing distribution agreements with supermarkets and pharmacies in Australia and with mother and baby stores and e-commerce platforms in China. This hasn't yet translated into meaningful sales, though, so I'm keeping my powder dry until I see evidence that Chinese consumers are interested in its product.
Redbubble Ltd (ASX: RBL)
I think that this e-commerce platform provider's strong performance so far in FY 2018 has been very impressive and deserves more recognition. Earlier this year the company reported revenue of $102.3 million for the first half of FY 2018, a solid increase of 30% on the prior corresponding period. The good news is that management appears confident that there will be more of the same in the second half, which could make it well worth taking a closer look at Redbubble.
Volpara Health Technologies Ltd (ASX: VHT)
I have been very impressed at the rate Volpara has been growing its annual recurring revenues (ARR). Earlier this month it advised that it has surpassed its FY 2018 ARR growth target of 200% several months before the end of the financial year. The company's ARR currently stands at NZ$3.6 million, up 223% on FY 2017's result. This has been driven by greater than expected market share gains in the United States. According to its latest release, approximately 3.2% of all women screened in the United States for breast cancer are now contracted to Volpara's software. Considering the quality of the product, I suspect these market share gains will continue in FY 2019 and beyond.
